PROVÁDĚCÍ ROZHODNUTÍ XXXXXX (XX) 2020/528
ze xxx 14. xxxxx 2020,
kterým xx schvalují xxxxxxxxxx x Xxxxxxxx, Xxxx, Xxxxx Xxxxxx, Xxxxxxxxx xxxxxxx a Xxxxxxx xx xxxxxx provádění xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, xxxxx x xxxxxx
(xxxxxxxx xxx xxxxxx X(2020) 2103)
(Xxxx x významem xxx XXX)
XXXXXXXX XXXXXX,
x xxxxxxx na Smlouvu x fungování Xxxxxxxx xxxx,
x xxxxxxx xx xxxxxxxxxx Xxxx 2000/258/XX xx xxx 20. xxxxxx 2000 o xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxxx testů xxx xxxxxxxxx účinnosti xxxxxxxxxx xxxxx xxxxx xxxxxxxxx&xxxx;(1), a zejména xx xx. 3 xxxx. 2 xxxxxxxxx xxxxxxxxxx,
xxxxxxxx k těmto xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/ES určuje xxxxxxxxx Xxxxxx xxxxçxxxx xx xxxxxxxx sanitaire xxx aliments (xxxx xxx „AFSSA“) xx xxxxxxxxxxxx Nancy xxxx xxxxxxxx xxxxxxxx odpovědný xx stanovení xxxxxxxx xxxxxxxxxx pro normalizaci xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx proti xxxxxxxxx. XXXXX xxxx nyní xxxxxxxxx do Xxxxxx xxxxxxxxx xx xxxxxxxx xxxxxxxxx xx x’xxxxxxxxxxxx, xx x’xxxxxxxxxxxxx et xx xxxxxxx (xxxx xxx „ANSES“) xx Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/XX xxxx xxxx xxxxxxx, že XXXXX xxxxxxx xxxxxxxxxx xx xxxxxxx zemích, xxxxx xxxxxxxxxx žádost x xxxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx xxx sledování xxxxxxxxx očkovacích látek xxxxx vzteklině. |
|
(3) |
Příslušný orgán x Xxxxxxxx xxxxxxxxx xxxxxx o xxxxxxxxx xxxxxxxxxx „Núcleo xx Xxxxxxxxx xx Raiva xx Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx x Xxxxxxxxx xx Instituto xx Xxêxxxxx Xxxxxxxxxx xx Xxxxxxxxxxxx de Xãx Xxxxx“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx příznivou xxxxxxxxx xxxxxx xx dne 24. xxxxx 2019, xxxxxx předložila Xxxxxx. |
|
(4) |
Xxxxxxxxx xxxxx Xxxx xxxxxxxxx xxxxxx x xxxxxxxxx xxxx xxxxxxxxxx: „Xxxx Xxxx World Biologicals Xxxxxxxxxxxxxx Xx., Xxx (Xxxxxx)“ x „Xxxxxx Xxxxxxx Diagnostic Xxxxxx xx xxx Xxxxxxxxx xx Xxxxxx Health xx xxx Guangdong Xxxxxxx xx Agriculture Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx xx dne 24. xxxxx 2019, kterou xxxxxxxxxx Komisi. |
|
(5) |
Příslušný xxxxx Xxxx předložil žádost x xxxxxxxx schválení xxxx xxxxxxxxxx: „Xxxxxxxx Xxxxxxxxx Xxxxxxxxxx xxx Xxxxxx Rabies (Xxxxxxxxxx Xxxxxxxxxx for Xxxxxx xxx Wildlife Associated Xxxxxxxx)“ x „Centre xxx Xxxxxx Antibody Xxxxx xx the Xxxxxxxxxx of Epidemiology xx xxx Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Institute xx xxx Xxxxxxx xx Xxxxxxxx Medical Xxxxxxxx“. XXXXX pro xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící xxxxxx xx dne 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(6) |
Xxxxxxxxx orgán Xxxxx Xxxxxx xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxx and Xxxxxxxx encephalitis OIE xxxxxxxxx xxxxxxxxxx xx Xxxxxx xxx Xxxxx Xxxxxxxxxx Xxxxxx“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. xxxxx 2019, xxxxxx xxxxxxxxxx Komisi. |
|
(7) |
Příslušný xxxxx Thajska xxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxxxxx „Xxxxxxxx Xxxxxxxxx xx Xxxxxx Health“. XXXXX xxx xxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. října 2019, kterou předložila Xxxxxx. |
|
(8) |
Xxxxxxxxx xxxxx Xxxxxxxxx xxxxx xxxxxxxxx žádost x xxxxxxxx xxxxxxxxx xxxxxxxxxx „Centers for Xxxxxxx Control xxx Xxxxxxxxxx xx xxx Xxxxxx Xxxxxxxxxx“. XXXXX xxx tuto xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx ze xxx 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(9) |
Xxxx xxxxxxxxxx by xxxxx xxxx xxx schváleny xx účelem provádění xxxxxxxxxxxxx xxxxx xxx xxxxxxxxx účinnosti očkovacích xxxxx proti xxxxxxxxx x psů, koček x xxxxxx. |
|
(10) |
Xxxxxxxx xxxxxxxxx xxxxx xxxxxxxxxxx xxxx x souladu xx xxxxxxxxxxx Xxxxxxx xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x xxxxxx, |
XXXXXXX XXXX XXXXXXXXXX:
Xxxxxx 1
X souladu x čl. 3 xxxx. 2 rozhodnutí 2000/258/XX xx xxx xxxxxxxxx xxxxxxxxxxxxx xxxxx xx xxxxxx xxxxxxxxx xxxxxxxxx očkovacích xxxxx xxxxx xxxxxxxxx u xxx, xxxxx x xxxxxx xxxxxxxxx xxxx xxxxxxxxxx:
|
x) |
Xxxxxx de Pesquisas xx Raiva Laboratório de Xxxxxxxxx Xxxxxxx x Xxxxxxxxx xx Xxxxxxxxx xx Ciências Xxxxxxxxxx Xxxxxxxxxxxx xx Xãx Xxxxx Xx. Xxxx. Xxxxx Xxxxxxx, 1374, xxxx 225 05508-000 Xãx Xxxxx Xxxxxxxx |
|
b) |
Sino Xxxx Xxxxx Xxxxxxxxxxx Pharmaceutical Xx., Xxx (Xxxxxxx) 29 Xxxxxxxx West Xxxx. Xxxxxxxxxx Xxxxxxxx Xxxx, Xxxxxx District, Xxxxxx Xxxx |
|
c) |
Animal Disease Xxxxxxxxxx Center Xxxxxxxxx xx Xxxxxx Health, Xxxxxxxxx Xxxxxxx xx Xxxxxxxxxxx Xxxxxxxx 21 Xxxxxxxxxx Street, Xxxxxx Xxxxxxxx Guangzhou, Xxxxxxxxx Xxxx |
|
x) |
National Xxxxxxxxx Laboratory xxx Xxxxxx Xxxxxx (Xxxxxxxxxx Xxxxxxxxxx xxx Rabies xxx Xxxxxxxx Associated Xxxxxxxx) Xxxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxxxx Xxxxxxx xx Xxxxxxxxxxxx Xxxxxxxx 666 Xxxxxxx West Road, Xxxxxxx Xxxxxxx Xxxxxxxxxxx Xxxxxxxx, Changchun, Xxxxx, Xxxx |
|
x) |
Xxxxxx xxx Xxxxxx Antibody Xxxxx, Laboratory xx Xxxxxxxxxxxx, Military Veterinary Xxxxxxxx Xxxxxxxxx, Xxxxxxx xx Military Xxxxxxx Xxxxxxxx 666 Xxxxxxx Xxxx Xxxx, Jingyue Xxxxxxx Xxxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Jilin Xxxx |
|
x) |
Xxxxxx xxx Japanese xxxxxxxxxxxx XXX xxxxxxxxx xxxxxxxxxx xx xxx Animal xxx Xxxxx Xxxxxxxxxx Xxxxxx 177 Hyeoksin 8-xx, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx for Xxxxxxx Xxxxxxx and Xxxxxxxxxx Xxxxxx Xxxxxxxxxx 1600 Xxxxxxx Road, XX, Atlanta, XX 30333, Xxxxxxx xxxxx americké |
|
x) |
Xxx Xxxxxxxx Xxxxxxxxx xx Xxxxxx Health 50/2 Xxxxxxxxxx, Xxxxxx, Xxxxxxxxx Xxxxxxx 10900 Xxxxxxx |
Xxxxxx 2
Xxxx xxxxxxxxxx xx xxxxxx xxxxxxxx xxxxxx.
X Xxxxxxx dne 14. dubna 2020.
Xx Xxxxxx
Xxxxxx XXXXXXXXXX
xxxxxx Komise
(1)&xxxx;&xxxx;Xx. xxxx. X 79, 30.3.2000, x. 40.